Inovio Pharmaceuticals
INO
INO
133 hedge funds and large institutions have $118M invested in Inovio Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
20% less call options, than puts
Call options by funds: $405K | Put options by funds: $504K
36% less capital invested
Capital invested by funds: $184M → $118M (-$66M)
Holders
133
Holding in Top 10
–
Calls
$405K
Puts
$504K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.32M | |
| 3 | +$1.03M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$590K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$588K |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$2.4M | |
| 3 | -$1.32M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$731K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$591K |